Accelerate your science at Novo Nordisk’s 2023 Pharma Day

Aug 16, 2023

MassBio is partnering with Novo Nordisk on October 26 to host Novo Nordisk Pharma Day 2023, an unparalleled opportunity for emerging innovators to learn from and connect with a leading global healthcare company that is driving change to defeat serious chronic diseases.  

What they’re saying: “Novo Nordisk has partnered with leading scientists for 100 years to transform innovative ideas into groundbreaking therapies. We are always looking for high-potential innovation and strategic partnerships to complement our existing capabilities. With our best-in-class research and development organization and global reach we are the right partner to bring innovative ideas to life and help unlock their full potential.” 

– John McDonald, Head of Business Development and M&A at Novo Nordisk 

Hear the latest: At Novo Nordisk’s open information session you will discover the latest insights on its R&D strategy, priority therapeutic areas, and partnering capabilities. This session will be followed by a networking reception. 

Get closer: Groundbreaking innovators across all stages of development with any therapeutic modality can apply for a one-on-one meeting with Novo Nordisk’s representatives during the day. Novo Nordisk’s priority therapeutic areas are:  

  • Diabetes   
  • Obesity  
  • Rare blood disorders  
  • Cardiovascular diseases  
  • Other serious chronic diseases (CKD, NASH)  

If your company meets their eligibility guidelines, apply for a 1:1 meeting by September 8, 2023 at 5:00PM ET.   

See all MassBio News